본문 바로가기
KERD
논문KCI 등재

공수병의 일반적 특징과 교상 후 치료

General Features and Post-Exposure Prophylaxis of Rabies

박준선|한명국
대한감염학회 (The Korean Society Of Infectious Diseases)|2010.02|Infection and Chemotherapy|제42권 제1호|pp. 6-11

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

vaccineRabiespost-exposure prophylaxis
주제분류내과학

초록

Rabies is a representative zoonotic disease caused by rabies virus. The discriminative features of rabies are broad range of hosts including humans, a wide variety of incubation periods ranging from a few weeks to more than a year, ability to bring about acute fetal consequence, and scare pathological lesions. Although rabies is fatal, it is preventable disease by vaccination and post-exposure prophylaxis (PEP). This review will focus on general features of rabies, and immunoglobulin and vaccines for PEP.

Abstract

Rabies is a representative zoonotic disease caused by rabies virus. The discriminative features of rabies are broad range of hosts including humans, a wide variety of incubation periods ranging from a few weeks to more than a year, ability to bring about acute fetal consequence, and scare pathological lesions. Although rabies is fatal, it is preventable disease by vaccination and post-exposure prophylaxis (PEP). This review will focus on general features of rabies, and immunoglobulin and vaccines for PEP.

참고문헌 (39)

  1. Rupprecht CE, "Rabies reexamined", Lancet Infect Dis, 2, pp.327~343 (2002)
  2. Smith JS, "Unexplained rabies in three immigrants in the United States. A virologic investigation", N Engl J Med, 324, pp.205~211 (1991)
  3. Grattan-Smith PJ, "Rabies. A second Australian case, with a long incubation period", Med J Aust, 156, pp.651~654 (1992)
  4. Johnson N, "Human rabies case with long incubation, Australia", Emerg Infect Dis, 14, pp.1950~1951 (2008)
  5. Jackson AC, "Management of rabies in humans", Clin Infect Dis, 36, pp.60~63 (2003)
  6. Wilde H, "Viewpoint : Management of human rabies", Trans R Soc Trop Med. Hyg, 102, pp.979~982 (2008)
  7. Hattwick MA, "Recovery from rabies. A case report", Ann Intern Med, 76, pp.931~942 (1972)
  8. Hattwick MAW, "Human rabies", Public Health Rev, 3, pp.229~274 (1974)
  9. Willoughby RE Jr, "Survival after treatment of rabies with induction of coma", N Engl J Med, 352, pp.2508~2514 (2005)
  10. Warrell MJ, "Rabies and other lyssavirus diseases", Lancet, 363, pp.959~969 (2004)
  11. Noah DL, "Epidemiology of human rabies in the United States, 1980 to 1996", Ann Intern Med, 128, pp.922~930 (1998)
  12. Kim CH, "Rabies, an emerging disease in Korea", J Vet Med B Infect Dis Vet Public Health, 53, pp.111~115 (2006)
  13. Korea Centers for Disease Control and Prevention, "Human Rabies Prevention & Control", ~ (2007)
  14. Han MY, "Epidemiological features of animal bite cases occurred in highly risk areas of rabies in Korea, 2005 to 2008", 20th International Conference on Rabies in the Americas, pp.45~46 (2009)
  15. "Rabies facts"[URL]
  16. Knobel DL, "Re-evaluating the burden of rabies in Africa and Asia", Bull World Health Organ, 83, pp.360~368 (2005)
  17. WHO, "WHO Expert Consultation on rabies", World Health Organ Tech Rep Ser, 931, pp.1~88 (2005)
  18. Bronnert J, "Organ transplantations and rabies transmission", J Travel Med, 14, pp.177~180 (2007)
  19. Conomy JP, "Airborne rabies encephalitis: demonstration of rabies virus in the human central nervous system", Neurology, 27, pp.67~69 (1977)
  20. Gibbons RV, "Cryptogenic rabies, bats, and the question of aerosol transmission", Ann Emerg Med, 39, pp.528~536 (2002)
  21. Johnson N, "Review of human rabies cases in the UK and in Germany", Vet Rec, 157, pp.715~ (2005)
  22. Srinivasan A, "Transmission of rabies virus from an organ donor to four transplant recipients", N Engl J Med, 352, pp.1103~1111 (2005)
  23. Pará M, "An outbreak of post-vaccinal rabies (rage de laboratoire) in Fortaleza, Brazil, in 1960. Residual fixed virus as the etiological agent", Bull World Health Organ, 33, pp.177~182 (1965)
  24. Jackson AC, "Rabies", Neurol Clin, 26, pp.717~726 (2008)
  25. Iwasaki Y, "Pathology in Rabies", pp.283~306 (2002), Academic Press
  26. Fu ZF, "Neuronal dysfunction and death in rabies virus infection", J Neurovirol, 11, pp.101~106 (2005)
  27. Dacheux L, "A reliable diagnosis of human rabies based on analysis of skin biopsy specimens", Clin Infect Dis, 47, pp.1410~1417 (2008)
  28. Woldehiwet Z, "Clinical laboratory advances in the detection of rabies virus", Clin Chim Acta, 351, pp.49~63 (2005)
  29. Crepin P, "Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid", J Clin Microbiol, 36, pp.1117~1121 (1998)
  30. Hemachudha T, "Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination", N Engl J Med, 316, pp.369~374 (1987)
  31. Piyasirisilp S, "Neurological adverse events associated with vaccination", Curr Opin Neurol, 15, pp.333~338 (2002)
  32. Swamy HS, "Clinical and therapeutic aspects", J Assoc Physicians India, 39, pp.667~669 (1991)
  33. "WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies"[URL]
  34. Rupprecht CE, "Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals", Vaccine, 27, pp.7141~7148 (2009)
  35. Aoki FY, "Intravenous human rabies immunoglobulin for postexposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects", J Biol Stand, 17, pp.91~104 (1989)
  36. Champion JM, "The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure", J Immunol Methods, 235, pp.81~90 (2000)
  37. Bakker AB, "First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity", Vaccine, 26, pp.5922~5927 (2008)
  38. Goudsmit J, "Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin", J Infect Dis, 193, pp.796~801 (2006)
  39. "Rabies vaccines. WHO position paper", Wkly Epidemiol Rec, 82, pp.425~435 (2007)

관련 논문AI추천

Prophylaxis of Human Hydrophobia in South Korea김양리대한감염학회 · Infection and Chemotherapy2014 · 제46권 제3호Rabies Post-Exposure Prophylaxis of Overseas Travelers in the International Travel Clinic of the National Medical Center from 2006 to 2012, Korea김재윤, Bum Sik Chin, Chang Hyu Lee, Hyung Sik Shin, Jae Yoon Kim, Youn Kyoung Won대한감염학회 · Infection and Chemotherapy2014 · 제46권 제1호소아청소년에서 공수병 예방접종 및 교상 후 조치 현황: 최근 5년간 국립중앙의료원에서의 경험김재윤, 노진철, 박종현, 박향미, 원연경, 이창휴대한소아감염학회 · Pediatric Infection and Vaccine2013 · 제20권 제1호광견병바이러스에 대한 단크론항체 생산 및 특성강신영, 송윤경, 우계형, 윤영심, 이승철, 진영화한국동물위생학회 · 한국동물위생학회지2010 · 제33권 제2호동물에서의 광견병 발생상황 및 대책이경기대한감염학회 · Infection and Chemotherapy2010 · 제42권 제1호서울지역 유기견의 광견병 바이러스 항체 분포 조사강영일, 김능희, 김세곤, 손홍락, 이정학, 채희선한국동물위생학회 · 한국동물위생학회지2011 · 제34권 제4호

이 간행물의 다른 논문 (11건)

동물에서의 광견병 발생상황 및 대책이경기pp. 1-5Detection of Human Cytomegalovirus (HCMV) and Porcine Endogenous Retrovirus (PERV) with One Step Extraction Method황응수, 김정헌, 정은숙pp. 12-16국내 혈액질환 환자에서 침습성 아스페르길루스증의 구제치료로서 Voriconazole의 효과와 안전성신완식, 최재기, 유진홍, 이동건, 권재철, 박선희, 최수미, 최정현, 김시현pp. 17-22레지오넬라 폐렴의 진단용 바이오마커의 발굴: A/J 마우스 감염 모델에서 Legionella pneumophila의 독력 유전자들의 발현양상 분석손장욱, 김정연, 박윤선, 박대원, 윤영경, 김희남, 김민자, 심희선, 김승민, 심호기pp. 23-29한국인 쯔쯔가무시병 환자에서 사이토카인 유전자의 다양성 조사김수연, 김태규, 위성헌, 장우임pp. 30-34
원문 보기